Search Results for "Recall Promus Heart Stent"

00:55 EST 14th February 2016 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...


Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Transplantation

Heart Failure HF

Matching News

A Dissolving Heart Stent Works, But Is It Any Better For Patients?

A dissolvable heart stent developed by Abbott Pharmaceuticals performed similarly to a conventional stent in a human clinical trial. But that might not make it better.

Abbott reports positive study results for its dissolving heart stent

A 2,000-patient multisite study showed promising results for Abbott's Absorb, a heart stent that dissolves completely.  -More- 

SynCardia's artificial heart driver recall labeled Class I by FDA

A recall involving 29 units of SynCardia Systems' Total Artificial Heart Freedom Driver system has been categorized by the FD -More- 

Dissolving stent for heart arteries passes first large test

Now you see it, now you don't. A new type of heart stent that works like dissolving stitches, slowly going away after it has done its job, passed its first major test in a large study, doctors said Mo...

Abbott: Positive Clinical Results of Absorb, a Naturally Dissolving Heart Stent

Abbott announced today positive one-year clinical results from the ABSORB 3 trial, which compared the safety and effectiveness of Abbott's fully dissolving Absorb heart stent to Xience, Abbott's mark...

Abbott dissolving stent succeeds in pivotal U.S. trial -study

Oct 12 (Reuters) - A novel dissolving heart stent developed by Abbott Laboratories proved comparably safe and effective as its market-leading Xience stent in a large, late-stage trial that will be use...

Abbott dissolving stent succeeds in pivotal U.S. trial: study

(Reuters) - A novel dissolving heart stent developed by Abbott Laboratories proved comparably safe and effective as its market-leading Xience stent in a large, late-stage trial that will be used to se...

Medtronic to recall loading system for heart device: FDA

(Reuters) - Medtronic Plc will recall 6,912 units of the loading system of a recently approved heart device after reports of the presence of particulates, the U.S. Food and Drug Administration said.

Matching PubMed Articles

Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.

This study sought to assess the incidence and clinical impact of stent fracture (SF) after the PROMUS Element platinum-chromium everolimus-eluting stent (PtCr-EES).

Investigation of fibrous cap stresses on vulnerable plaques leading to heart attacks.

Rupture-prone plaques in the coronary arteries, called ``vulnerable plaques'', are recognized as the key factor in acute myocardial infarction. Vulnerable plaques have a thin fibrous cap over a large ...

Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.

Fibrin deposition and absent endothelium characterize unhealed stents that are at heightened risk of stent thrombosis. Optical coherence tomography (OCT) is increasingly used for assessing stent tissu...

Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.

Drug-eluting stents (DES) reduce restenosis, as compared with bare-metal stents (BMS); however, the relationship between stent type and health status is unknown. We examined whether stent type was ass...

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†.

Stent thrombosis (ST) is a rare but serious complication following percutaneous coronary intervention. Analysis of thrombus composition from patients undergoing catheter thrombectomy may provide impor...

Search Whole site using Google

Quick Search
Advertisement Advertisement